Chronic disease accounts for almost 70 % of the federal government's disease-related spending. CDM has the potential to become a very large industry in economic terms. Changes to health insurance legislation present service providers and insurers with new opportunities for the provision of CDM services in both the public and private systems.
Specific issues to be covered include:
- Forces driving the increase in chronic care cost in Australia
- The role of government policy, funding, regulation and education
- Growth opportunities arising from the changes to health insurance
- Evaluating the effectiveness of CDM programs
- Coordinating the care of multiple chronic diseases
- The role of information technology in managing chronic disease
- The financial impact of chronic disease in the workforce
Featuring prominent speakers including:
- Ms. Louise Stewart, Managing Director, Revive Group
- Dr. Paul Gross, Director, Institute of Health Economics & Technology Assessment
- Dr. John Lang, President HAPIA, Managing Director, Good Health Solutions